(VIANEWS) - Generac Holdlings (GNRC), Mimecast Limited (MIME), Novo Nordisk A/S (NVO) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Generac Holdlings (GNRC)
35.3% sales growth and 33.97% return on equity
Generac Holdings Inc. manufactures and sells energy storage and power generation products worldwide.
Generac Holdlings's sales growth this year is anticipated to be 49.7% and 17.9% for next year.
Year-on-year quarterly revenue growth grew by 69.7%, now sitting on 2.82B for the twelve trailing months.
Volume
Today's last reported volume for Generac Holdlings is 514585 which is 37.62% below its average volume of 825025.
Generac Holdlings's sales growth for the next quarter is 35.3%. The company's growth estimates for the present quarter and the next is 14.9% and 39.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 33.97%.
Volatility
Generac Holdlings's last day, last week, and last month's current intraday variation average was 3.32%, 2.41%, and 2.94%, respectively.
Generac Holdlings's highest amplitude of average volatility was 3.18% (day), 2.94% (last week), and 4.22% (last month), respectively.
Generac Holdlings's Stock Yearly Top and Bottom Value
Generac Holdlings's stock is valued at $287.22 at 11:22 EST, way below its 52-week high of $524.31 and way above its 52-week low of $213.50.
Generac Holdlings's Moving Average
Generac Holdlings's worth is way below its 50-day moving average of $433.60 and way under its 200-day moving average of $389.04.2. Mimecast Limited (MIME)
14.1% sales growth and 11.73% return on equity
Mimecast Limited offers cloud security and risk management for email and corporate data.
Mimecast Limited's sales growth this year is expected to be 18.2% and 14.8% for next year.
Year-on-year quarterly revenue growth grew by 20%, now sitting on 553.31M for the twelve trailing months.
Volume
Today's last reported volume for Mimecast Limited is 993093 which is 47.53% below its average volume of 1892930.
Mimecast Limited's sales growth is a negative 0% for the present quarter and 14.1% for the next. The company's growth estimates for the ongoing quarter and the next is 6.1% and 10.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.73%.
Volatility
Mimecast Limited's last day, last week, and last month's current intraday variation average was 0.05%, 0.25%, and 0.15%, respectively.
Mimecast Limited's highest amplitude of average volatility was 0.19% (day), 0.49% (last week), and 0.36% (last month), respectively.
Mimecast Limited's Stock Yearly Top and Bottom Value
Mimecast Limited's stock is valued at $79.33 at 11:22 EST, under its 52-week high of $85.48 and way above its 52-week low of $38.84.
Mimecast Limited's Moving Average
Mimecast Limited's worth is below its 50-day moving average of $79.53 and way higher than its 200-day moving average of $70.20.Previous days news about Mimecast Limited(MIME)
- According to Benzinga on Monday, 4 April, "SINGAPORE, April 03, 2022 (GLOBE NEWSWIRE) -- Email security and cyber resilience company Mimecast Limited MIME, has today announced it is continuing its expansion in APAC by establishing an office in Singapore as a regional hub for focus on South-East Asia. "
3. Novo Nordisk A/S (NVO)
11.2% sales growth and 70.63% return on equity
Novo Nordisk A/S is a global healthcare company that specializes in research, development and manufacture of pharmaceutical products.
Novo Nordisk A/S's sales growth this year is anticipated to be 7.3% and 8.3% for next year.
Year-on-year quarterly revenue growth grew by 10.1%, now sitting on 129.91B for the twelve trailing months.
Volume
Today's last reported volume for Novo Nordisk A/S is 1182290 which is 16.97% below its average volume of 1424060.
Novo Nordisk A/S's sales growth for the next quarter is 11.2%. The company's growth estimates for the present quarter and the next is 6.9% and 12.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 70.63%.
Volatility
Novo Nordisk A/S's last day, last week, and last month's current intraday variation average was 1.04%, 1.63%, and 1.79%, respectively.
Novo Nordisk A/S's highest amplitude of average volatility was 1.29% (day), 1.57% (last week), and 1.76% (last month), respectively.
Novo Nordisk A/S's Stock Yearly Top and Bottom Value
Novo Nordisk A/S's stock is valued at $120.56 at 11:22 EST, above its 52-week high of $115.95.
Novo Nordisk A/S's Moving Average
Novo Nordisk A/S's value is way higher than its 50-day moving average of $107.59 and way above its 200-day moving average of $90.32.4. Mondelez International (MDLZ)
7.3% sales growth and 16.31% return on equity
Mondelez International, Inc., via its subsidiaries, produces, markets, sells and distributes worldwide snack foods and beverages.
Mondelez International's sales growth this year is anticipated to be 7.8% and 3.9% for next year.
Year-on-year quarterly revenue growth grew by 7.8%, now sitting on 28.36B for the twelve trailing months.
Volume
Today's last reported volume for Mondelez International is 6069300 which is 28.93% below its average volume of 8540400.
Mondelez International's sales growth for the next quarter is 7.3%. The company's growth estimates for the current quarter and the next is 7.5% and 2.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.31%.
Volatility
Mondelez International's last day, last week, and last month's current intraday variation average was 0.81%, 0.44%, and 0.63%, respectively.
Mondelez International's highest amplitude of average volatility was 1.27% (day), 1.62% (last week), and 1.53% (last month), respectively.
Mondelez International's Stock Yearly Top and Bottom Value
Mondelez International's stock is valued at $63.33 at 11:22 EST, below its 52-week high of $69.47 and above its 52-week low of $57.63.
Mondelez International's Moving Average
Mondelez International's value is below its 50-day moving average of $64.48 and higher than its 200-day moving average of $62.97.5. Provident Bancorp (PVBC)
5.9% sales growth and 6.87% return on equity
Provident Bancorp, Inc. is the bank holding company of The Provident Bank. It provides financial services for individuals, small and medium-sized businesses throughout the United States.
Provident Bancorp's sales growth this year is expected to be 11.7% and 7% for next year.
Year-on-year quarterly revenue growth grew by 6.4%, now sitting on 62.71M for the twelve trailing months.
Volume
Today's last reported volume for Provident Bancorp is 11570 which is 58.83% below its average volume of 28106.
Provident Bancorp's sales growth for the next quarter is 5.9%. The company's growth estimates for the ongoing quarter and the next is 4.2% and negative -4.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.87%.
Volatility
Provident Bancorp's last day, last week, and last month's current intraday variation average was 1.03%, 0.96%, and 1.61%, respectively.
Provident Bancorp's highest amplitude of average volatility was 1.34% (day), 1.44% (last week), and 2.83% (last month), respectively.
Provident Bancorp's Stock Yearly Top and Bottom Value
Provident Bancorp's stock is valued at $15.76 at 11:22 EST, way under its 52-week high of $20.14 and way higher than its 52-week low of $14.14.